Cathelicidin Fragments and D-Enantiomers: Designing Better Antimicrobial Peptides
Study of cathelicidin PMAP-36 and BMAP-27 fragments plus D-enantiomers reveals design strategies for more stable, potent antimicrobial peptides.
Quick Facts
What This Study Found
Study of cathelicidin PMAP-36 and BMAP-27 fragments plus D-enantiomers reveals design strategies for more stable, potent antimicrobial peptides.
Key Numbers
Two peptide fragments tested: PMAP(12-24) and BMAP(1-18), plus their all-D-amino acid enantiomers. Tested for antimicrobial activity and protease resistance.
How They Did This
Study design and methodology detailed in the full publication.
Why This Research Matters
These findings have significant implications for peptide-based therapeutic development and clinical practice.
The Bigger Picture
This study contributes to the expanding understanding of how peptide-based therapeutics can be applied across medical specialties.
What This Study Doesn't Tell Us
Study-specific limitations discussed in the full publication. Results should be interpreted within the context of study design.
Questions This Raises
- ?What are the long-term implications?
- ?How do these results compare to existing evidence?
- ?What further research is needed?
Trust & Context
- Key Stat:
- Key finding Study of cathelicidin PMAP-36 and BMAP-27 fragments plus D-enantiomers reveals design strategies for
- Evidence Grade:
- Evidence assessment based on study design detailed in publication.
- Study Age:
- Published in 2025. Current peptide therapeutic research.
- Original Title:
- Fragments of cathelicidins PMAP-36 and BMAP-27 and their D-enantiomers: Effects of all D substitutions on structure, protease resistance and antimicrobial properties.
- Published In:
- Bioorganic chemistry, 163, 108715 (2025)
- Authors:
- Albini, Francesca, Biondi, Barbara, Di Stasi, Adriana, Schivo, Andrea, Mardirossian, Mario, Scocchi, Marco, Peggion, Cristina
- Database ID:
- RPEP-09848
Evidence Hierarchy
Frequently Asked Questions
What does this study mean for patients?
Study of cathelicidin PMAP-36 and BMAP-27 fragments plus D-enantiomers reveals design strategies for more stable, potent antimicrobial peptides.
How reliable are these findings?
Evidence strength depends on study design. Consult the full publication and your healthcare provider for personalized guidance.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-09848APA
Albini, Francesca; Biondi, Barbara; Di Stasi, Adriana; Schivo, Andrea; Mardirossian, Mario; Scocchi, Marco; Peggion, Cristina. (2025). Fragments of cathelicidins PMAP-36 and BMAP-27 and their D-enantiomers: Effects of all D substitutions on structure, protease resistance and antimicrobial properties.. Bioorganic chemistry, 163, 108715. https://doi.org/10.1016/j.bioorg.2025.108715
MLA
Albini, Francesca, et al. "Fragments of cathelicidins PMAP-36 and BMAP-27 and their D-enantiomers: Effects of all D substitutions on structure, protease resistance and antimicrobial properties.." Bioorganic chemistry, 2025. https://doi.org/10.1016/j.bioorg.2025.108715
RethinkPeptides
RethinkPeptides Research Database. "Fragments of cathelicidins PMAP-36 and BMAP-27 and their D-e..." RPEP-09848. Retrieved from https://rethinkpeptides.com/research/albini-2025-fragments-of-cathelicidins-pmap36
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.